Okmetic Oyj - Notice to convene extr.general meeting

OKMETIC TO CONVENE AN EXTRAORDINARY GENERAL MEETING ON 6 NOVEMBER 2008 AT 8.30 A.M.

OKMETIC OYJ STOCK EXCHANGE RELEASE 8 OCTOBER 2008 AT 11.15 A.M.	1(4)

OKMETIC TO CONVENE AN EXTRAORDINARY GENERAL MEETING ON 6 NOVEMBER 2008 AT 8.30
A.M. 

The board of directors of Okmetic Oyj has decided to convene an extraordinary
general meeting on Thursday 6 November 2008 at 8.30 a.m. The meeting will be
held in the Seutula conference room in Okmetic's head office at Piitie 2 in
Koivuhaka, Vantaa, Finland. 

The official notice of general meeting will be published in the Helsingin
Sanomat newspaper on Wednesday 15 October 2008. 
The agenda for the meeting will include:

1. Appointing a new member of the board of directors

Okmetic Oyj's shareholders Outokumpu Oyj and Accendo Capital, which together
hold approximately 31.8 percent of the company's shares and the associated
votes, have announced that they will be putting forward a proposal at the
extraordinary general meeting for an additional member to be appointed to join
the current five members of the company's board of directors and for the new
member to be remunerated proportionally to the length of his term of office as
per the decision of the annual general meeting of 3 April 2008. 

The shareholders in question propose that the new member be Henri Österlund,
M.Sc. (Economics and Business Administration), who has agreed to the
appointment. Mr Österlund is the managing director of Accendo Capital Partners
Oy, and he has held several positions within the capital market over several
years. 

2. The board of directors' authorisation to decide on repurchasing the
company's own shares 

The board of directors will be putting forward a proposal at the extraordinary
general meeting for the company's board of directors to be authorised to decide
on repurchasing the company's own shares as follows: 

The aggregate number of shares repurchased on the basis of the authorisation
cannot exceed 1,688,750 shares, which represents 10 percent of all the shares
of the company. The company and its subsidiaries together cannot at any time
own more than 10 percent of all of the company's registered shares. 

Only unrestricted shareholders' equity can be used to repurchase the company's
own shares under the authorisation. Own shares can be repurchased at a price
determined by public trading on the day of repurchase or at another
market-based price. 

The board of directors can decide the method of repurchasing the company's own
shares as well as the other terms and conditions. Derivatives, for example, can
be used in the repurchase. Shares can be repurchased independently of the
shareholders' proportional share holdings (directed repurchase). The board of
directors proposes that the authorisation remain in force until the annual
general meeting of spring 2010, however, until no later than 6 May 2010. 

3. The board of directors' authorisation to decide on transferring rights to
the company's own shares 

The board of directors will be putting forward a proposal at the extraordinary
general meeting for the company's board of directors to be authorised to decide
on share issues for transferring rights to the company's own shares as follows: 

The aggregate number of rights transferred on the basis of the authorisation
cannot exceed 1,688,750 shares, which represents 10 percent of all the shares
of the company. 

The board of directors will be authorised to decide on all the terms and
conditions of the share issues. The authorisation will be limited to
transferring rights to the company's own shares as held by the company. The
share issue can be carried out as a directed issue. The board of directors may
also decide to cancel the repurchased shares. The authorisation will be
effective until further notice, however, until no later than 30 June 2013.
Moreover, the authorisation cannot override the authorisation granted at the
annual general meeting of 3 April 2008 regarding share issues. 

Participation at the extraordinary general meeting

All shareholders who have by no later than Monday 27 October 2008 been recorded
as shareholders in the list of owners kept by the Nordic Central Securities
Depository have the right to attend the meeting. Shareholders with nominee
registration can take part in the meeting providing that they have no later
than on Monday 27 October 2008 been temporarily added to the list of
shareholders. Shareholders with nominee accounts held by custodian banks must
contact their broker well in advance of the aforementioned date in order to
take part in the meeting. 

Registration

Shareholders who wish to attend the meeting should inform the head office of
Okmetic Oyj thereof by Wednesday 29 October 2008 (at Piitie 2, Vantaa, room
5.1.31) during office hours from Monday to Friday between 8.00 a.m. and 4.00
p.m. Registration is also possible via email at shareholders@okmetic.com, by
telephone on +358 9 5028 0406, or by post to Okmetic Oyj, Share Register, P.O.
Box 44, FI-01301 Vantaa, Finland. In addition to their name, shareholders are
asked to provide their personal identity code or business identity code.
Registration by post requires that the letter arrive before the end of the
registration period. Should the participant be a legal representative whom a
shareholder has given the right to vote by proxy, this should be disclosed in
connection with registration and the proxy statement should be left or supplied
to the company's head office within the duration of the registration period. 

Documents on display for public inspection

The aforementioned proposals of the board of directors, the company's most
recent financial statements, annual report and auditor's report, as well as the
interim reports produced after the end of the most recently concluded financial
year (of which the report for the period of 1 January - 30 September 2008 will
be published on 30 October 2008, and includes the board of directors' report on
events that have taken place after the release of the interim report insofar as
they significantly affect the company's position) will be available for the
shareholders to inspect in room 5.1.31 of the company's head office at Piitie 2
in Koivuhaka, Vantaa from Thursday 30 October 2008 onwards. From the
aforementioned date onwards, shareholders can ask the company to supply a copy
of the aforementioned documents. The proposals of the board of directors will
also be on display at the extraordinary general meeting and can be found online
at http://www.okmetic.com/www/page/investors. 

Vantaa, 7 October 2008

Board of directors

For more information, please contact:

Senior Vice President, Finance Esko Sipilä, Okmetic Oyj,
Tel. +358 9 5028 0286, email: esko.sipila@okmetic.com

Distribution:

OMX Nordic Exchange
Principal media
www.okmetic.com

OKMETIC IN BRIEF

Take it higher

Okmetic is a technology company which supplies tailor-made silicon wafers for
sensor and semiconductor industries and sells its technological expertise.
Okmetic provides its customers with solutions that boost their competitiveness
and profitability. 

Okmetic's silicon wafers are part of a further processing chain that produces
end products that improve human interaction and quality of life. Okmetic's
products are based on high-tech expertise that generates added value for
customers, innovative product development and efficient production process. 

Okmetic has a global customer base and sales network, production plants in
Finland and the US and contract manufacturers in Japan and China. 

Okmetic's shares are listed on OMX Nordic Exchange under the code OKM1V. For
more information on the company, please visit our website at www.okmetic.com.